115 related articles for article (PubMed ID: 38400788)
1. Choice of Adjuvant Radiotherapy Facility in Major Salivary Gland Cancer.
Patel AM; Haleem A; Maxwell R; Lukens JN; Lin A; Brody RM; Brant JA; Carey RM
Laryngoscope; 2024 Feb; ():. PubMed ID: 38400788
[TBL] [Abstract][Full Text] [Related]
2. Patterns and Trends in Adjuvant Therapy for Major Salivary Gland Cancer.
Patel AM; Haleem A; Choudhry HS; Povolotskiy R; Roden DF
Otolaryngol Head Neck Surg; 2024 Mar; ():. PubMed ID: 38482915
[TBL] [Abstract][Full Text] [Related]
3. Impact of treating facilities' type and volume in patients with major salivary gland cancer.
Bollig CA; Zitsch RP
Laryngoscope; 2019 Oct; 129(10):2321-2327. PubMed ID: 30698823
[TBL] [Abstract][Full Text] [Related]
4. Extranodal extension in laryngeal squamous cell carcinoma.
Patel AM; Vedula S; Shaari AL; Choudhry HS; Filimonov A
Laryngoscope Investig Otolaryngol; 2024 Apr; 9(2):e1232. PubMed ID: 38529341
[TBL] [Abstract][Full Text] [Related]
5. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
[TBL] [Abstract][Full Text] [Related]
6. Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?
Malik AT; Alexander JH; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Mar; 478(3):631-642. PubMed ID: 31714413
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Radiation Therapy Refusal in Major Salivary Gland Cancers.
Shah KV; Carey RM; Prasad A; Panara K; Rajasekaran K; Cannady SB; Brant JA; Brody RM
Otolaryngol Head Neck Surg; 2023 Sep; 169(3):577-588. PubMed ID: 36939552
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Primary Tumor Extent and Postoperative Radiation Facility Location in Major Salivary Gland Malignancies.
Ladbury C; Liu J; Nelson R; Amini A; Maghami E; Sampath S
Cureus; 2022 Apr; 14(4):e24038. PubMed ID: 35547406
[TBL] [Abstract][Full Text] [Related]
9. The impact of treatment facility type on the survival of brain metastases patients regardless of the primary cancer type.
Amin S; Baine M; Meza J; Lin C
BMC Cancer; 2021 Apr; 21(1):387. PubMed ID: 33836694
[TBL] [Abstract][Full Text] [Related]
10. Elective Neck Dissection for cT1-4 N0M0 Head and Neck Verrucous Carcinoma.
Patel AM; Vedula S; Haleem A; Choudhry HS; Tseng CC; Park RCW
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1187-1199. PubMed ID: 37278222
[TBL] [Abstract][Full Text] [Related]
11. Elective Neck Dissection in cT1-4 N0M0 Head and Neck Basaloid Carcinoma.
Patel AM; Haleem A; Choudhry HS; Brody RM; Brant JA; Carey RM
Otolaryngol Head Neck Surg; 2024 Apr; ():. PubMed ID: 38613196
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.
Lee NCJ; Kelly JR; An Y; Park HS; Judson BL; Burtness BA; Husain ZA
Cancer; 2019 Jun; 125(12):2018-2026. PubMed ID: 30748002
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.
Graboyes EM; Townsend ME; Kallogjeri D; Piccirillo JF; Nussenbaum B
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1154-1163. PubMed ID: 27435696
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer.
Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA
Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018
[TBL] [Abstract][Full Text] [Related]
16. Regionalization of head and neck cancer surgery may fragment care and impact overall survival.
Chen MM; Megwalu UC; Liew J; Sirjani D; Rosenthal EL; Divi V
Laryngoscope; 2019 Jun; 129(6):1413-1419. PubMed ID: 30152007
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Time to Postoperative Radiation Therapy on Survival in Resected Merkel Cell Carcinoma.
Shinde A; Verma V; Jones BL; Li R; Glaser S; Freeman M; Melstrom L; Kang R; Parvathaneni U; Modi B; Amini A
Am J Clin Oncol; 2019 Aug; 42(8):636-642. PubMed ID: 31246585
[TBL] [Abstract][Full Text] [Related]
18. The role of elective neck dissection in patients with adenoid cystic carcinoma of the head and neck.
Xiao R; Sethi RKV; Feng AL; Fontanarosa JB; Deschler DG
Laryngoscope; 2019 Sep; 129(9):2094-2104. PubMed ID: 30667061
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Salivary Cancer: Epidemiology, Treatment Trends, and Association of Treatment Modality with Survival.
Morse E; Fujiwara RJT; Husain Z; Judson B; Mehra S
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):553-563. PubMed ID: 29688836
[TBL] [Abstract][Full Text] [Related]
20. Treatment Times in Salivary Gland Cancer: National Patterns and Association with Survival.
Morse E; Fujiwara RJT; Judson B; Mehra S
Otolaryngol Head Neck Surg; 2018 Aug; 159(2):283-292. PubMed ID: 29460669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
